DT
HealthMore in Health→
Stable PSA Readings May Miss Prostate Cancer Progression, Trial Analysis Finds
Key Takeaways
- A large analysis of two clinical trials found scans can detect progression despite stable biomarkers.
- The finding applies to patients treated with androgen receptor pathway inhibitors.
- The result suggests biomarker stability alone may not be enough to rule out advancing disease.
DE
DT Editorial Team··via medicalxpress.com